Here’s what you should know.
1. Allergan reported earnings per share of $3.90 for its fourth quarter, beating analysts’ estimates of $3.76 EPS.
2. The company’s $3.86 billion in revenues for Q4 also exceeded analysts’ expectations of $3.77 billion.
3. Allergan’s stock opened at $245.68 on Feb. 10, 2017.
4. The company’s 52-week high is $301.32 and 52-week low is $184.50.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Warren Butt of Gastroenterology Associates
Drs. Glenn Eisen, David Carr-Locke & more — 4 GI physicians in the headlines
Column: Can frozen stool replace fresh in fecal transplants? 5 key notes
